Application 076373
- Type
- ANDA
- Sponsor
- TEVA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CARVEDILOL | CARVEDILOL | TABLET;ORAL | 3.125MG | No | No |
| 002 | CARVEDILOL | CARVEDILOL | TABLET;ORAL | 6.25MG | No | No |
| 003 | CARVEDILOL | CARVEDILOL | TABLET;ORAL | 12.5MG | No | No |
| 004 | CARVEDILOL | CARVEDILOL | TABLET;ORAL | 25MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076373-001 | CARVEDILOL | CARVEDILOL | 3.125MG | TABLET / ORAL | AB | 2007-09-05 | |
| A076373-002 | CARVEDILOL | CARVEDILOL | 6.25MG | TABLET / ORAL | AB | 2007-09-05 | |
| A076373-003 | CARVEDILOL | CARVEDILOL | 12.5MG | TABLET / ORAL | AB | 2007-09-05 | |
| A076373-004 | CARVEDILOL | CARVEDILOL | 25MG | TABLET / ORAL | AB | 2007-09-05 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A076373-001 | AB |
| A076373-002 | AB |
| A076373-003 | AB |
| A076373-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A076373-001 | CARVEDILOL | 3.125MG | TABLET / ORAL | AB | 2007-09-05 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A076373-002 | CARVEDILOL | 6.25MG | TABLET / ORAL | AB | 2007-09-05 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A076373-003 | CARVEDILOL | 12.5MG | TABLET / ORAL | AB | 2007-09-05 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A076373-004 | CARVEDILOL | 25MG | TABLET / ORAL | AB | 2007-09-05 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A076373-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A076373-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A076373-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A076373-004 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Carvedilol | CARVEDILOL | A-S Medication Solutions | fe2d5c95-c101-4b01-89fd-0fd6d25ad80b | 2026-04-26 | Warnings, Adverse reactions | 076373 ANDA076373 |
| Carvedilol | CARVEDILOL | Proficient Rx LP | 8db9cddd-0ee7-4ce8-a8c9-c5e043b2838a | 2026-03-01 | Warnings, Adverse reactions | 076373 ANDA076373 |
| Carvedilol | CARVEDILOL | QPharma, Inc. | ffbedcce-0d64-4aed-9e65-09448d71ca91 | 2025-12-05 | Warnings, Adverse reactions | 076373 ANDA076373 42708-072 |
| Carvedilol | CARVEDILOL | Proficient Rx LP | 52785a22-ddca-4f5b-8579-5974df2a9a4e | 2025-12-01 | Warnings, Adverse reactions | 076373 ANDA076373 |
| Carvedilol | CARVEDILOL | NCS HealthCare of KY, LLC dba Vangard Labs | 2fb46fe1-9b7b-4718-9327-2471af22f0b7 | 2025-06-11 | Warnings, Adverse reactions | 076373 ANDA076373 0615-8388 0615-8387 0615-8389 0615-8390 |
| Carvedilol | CARVEDILOL | Proficient Rx LP | da2696ba-f4be-4626-9abe-fe33f36361b1 | 2025-05-01 | Warnings, Adverse reactions | 076373 ANDA076373 |
| Carvedilol | CARVEDILOL | Proficient Rx LP | c0202d0f-2ffc-45f2-a98d-5f05ac1eaa85 | 2025-02-01 | Warnings, Adverse reactions | 076373 ANDA076373 |
| Carvedilol | CARVEDILOL | Teva Pharmaceuticals USA, Inc. | 68c275e8-992a-4520-8065-ab6d615d89cc | 2024-03-25 | Warnings, Adverse reactions | 076373 ANDA076373 0093-7295 0093-7296 0093-0135 0093-0051 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-0051 | Carvedilol | Carvedilol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-0051 | Carvedilol | Carvedilol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-0051 | Carvedilol | Carvedilol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-0135 | Carvedilol | Carvedilol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-0135 | Carvedilol | Carvedilol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-0135 | Carvedilol | Carvedilol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7295 | Carvedilol | Carvedilol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7295 | Carvedilol | Carvedilol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7295 | Carvedilol | Carvedilol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7296 | Carvedilol | Carvedilol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7296 | Carvedilol | Carvedilol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7296 | Carvedilol | Carvedilol | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0615-8387 | Carvedilol | Carvedilol | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | Current |
| 0615-8387 | Carvedilol | Carvedilol | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | Current |
| 0615-8388 | Carvedilol | Carvedilol | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | Current |
| 0615-8388 | Carvedilol | Carvedilol | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | Current |
| 0615-8389 | Carvedilol | Carvedilol | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | Current |
| 0615-8389 | Carvedilol | Carvedilol | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | Current |
| 0615-8390 | Carvedilol | Carvedilol | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | Current |
| 0615-8390 | Carvedilol | Carvedilol | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | Current |
| 42708-072 | Carvedilol | Carvedilol | QPharma Inc | ANDA | Current |
| 42708-072 | Carvedilol | Carvedilol | QPharma Inc | ANDA | Current |
| 42708-072 | Carvedilol | Carvedilol | QPharma Inc | ANDA | Current |
| 50090-5115 | Carvedilol | Carvedilol | A-S Medication Solutions | ANDA | Current |
| 50090-5115 | Carvedilol | Carvedilol | A-S Medication Solutions | ANDA | Current |
| 66116-361 | Carvedilol | Carvedilol | MedVantx, Inc. | ANDA | Current |
| 66116-429 | Carvedilol | Carvedilol | MedVantx, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 8902 | ORIG | 2007-09-07 |